Erectile Dysfunction (ED) is an incurable sexual condition, but treatable. Men are quite lucky to have so many oral medicines to manage erectile dysfunction, and one of them is Filitra.
Before the inception of oral ED drugs, it was tough for many men to receive ED treatment. That’s because physicians advised impotent men to undergo invasive procedures such as penile implants, vacuum device or pump insertion and even vascular surgery. Many men were hesitant to receive such painful ED treatments.
In late 90s, when a drug called Sildenafil Citrate was undergoing clinical trials for the treatment of pulmonary hypertension, scientists accidently found that it is helping men achieve harder and durable erection. Since then, oral medicines are widely used. Other ED drugs such as Tadalafil and Vardenafil followed the trait.
Filitra is a generic medicine that contains Vardenafil as an active component. It manages penile failure efficiently by boosting the blood flow to the male sexual organ. It does so by suppressing the action of an enzyme phosphodiesterase-5 and by increasing the level of nitric oxide. The elevation in nitric oxide augments the blood supply to the penile organ for an erection that sustains for longer duration. This way, with the help of Filitra, you can achieve erection and make love satisfactorily.
Filitra is available in 20mg and 40mg potencies. Also, it is available in an innovative pill form that is to be used sublingually. The prescribed dose of this generic ED medicine is ought to be consumed at least half an hour before sexual activity. Keep proper gap of 24 hours between two doses to stay away from overdose complications. Remember, the medicine only works in the presence of sexual stimulation.
Side effects with this medicine are quite rare. The common ones include nausea, headache, dizziness, blurry vision and nasal congestion that usually subside. Filitra is not advised for men who are already taking nitrates or alpha-blockers. Hence, it is always better to use Filitra after discussing with doctor.